Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/1994
Title: | Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial | Authors: | Bogaerts, J. Cardoso, F. BUYSE, Marc Braga, S. Loi, S. Harrison, J. A. Bines, J. Mook, S. Decker, N. Ravdin, P. Therasse, P. Rutgers, E. van't Veer, L. J. Piccart, M. |
Issue Date: | 2006 | Publisher: | NATURE PUBLISHING GROUP | Source: | NATURE CLINICAL PRACTICE ONCOLOGY, 3(10). p. 540-551 | Abstract: | This Review describes the work conducted by the TRANSBIG consortium in the development of the MINDACT (Microarray In Node negative Disease may Avoid ChemoTherapy) trial. The goal of the trial is to provide definitive evidence regarding the clinical relevance of the 70-gene prognosis signature, and to assess the performance of this signature compared with that of traditional prognostic indicators for assigning adjuvant chemotherapy to patients with node-negative breast cancer. We outline the background work and the key questions in node-negative early-stage breast cancer, and then focus on the MINDACT trial design and statistical considerations. The challenges inherent in this trial in terms of logistics, implementation and interpretation of the results are also discussed. We hope that this article will trigger further discussion about the difficulties of setting up and analyzing trials aimed at establishing the worth of new methods for better selection of patients for cancer treatment. | Notes: | Inst Jules Bordet, Chemotherapy Unit, B-1000 Brussels, Belgium. Free Univ Brussels, B-1050 Brussels, Belgium. Univ Texas, San Antonio, TX 78285 USA. Breast Int Grp, Brussels, Belgium. Netherlands Canc Inst, Amsterdam, Netherlands. Hasselt Univ, Diepenbeek, Belgium. IDDI, Diepenbeek, Belgium. Inst Jules Bordet, Dept Med, B-1000 Brussels, Belgium. EORTC, Res Ctr, Brussels, Belgium. EORTC, Ctr Data, Brussels, Belgium. EORTC, Breast Canc Grp, Brussels, Belgium. EORTC, Head & Neck Canc Grp, Brussels, Belgium.Cardoso, F, Inst Jules Bordet, Chemotherapy Unit, Blvd Waterloo 125, B-1000 Brussels, Belgium.fatima.cardoso@bordet.be | Keywords: | breast cancer; chemotherapy; MINDACT; prognostic; validation | Document URI: | http://hdl.handle.net/1942/1994 | ISSN: | 1743-4254 | DOI: | 10.1038/ncponc0591 | ISI #: | 000241054700007 | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2007 |
Appears in Collections: | Research publications |
Show full item record
SCOPUSTM
Citations
202
checked on Sep 3, 2020
WEB OF SCIENCETM
Citations
191
checked on Oct 6, 2024
Page view(s)
110
checked on May 23, 2023
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.